FINWIRES · TerminalLIVE
FINWIRES

Docebo公佈第一季未經審計的初步業績後,美國盤前股價上漲1%;並更新了2026財年展望。

-- 提供人工智慧勞動力準備平台的Docebo(DCBO.TO)週二在美國盤前交易中上漲1%,此前該公司公佈了截至2026年3月31日的第一季度未經審計的初步財務業績,並上調了截至2026年12月31日的財年業績預期。 在未經審計的第一季初步財務業績中,該公司表示,預計總收入將在6,540萬美元至6,560萬美元之間,較2025年第一季的5,730萬美元成長14.3%。 FactSet匯總的第一季銷售額普遍預期為6,350萬美元。 該公司也表示,截至2026年3月31日止三個月的調整後EBITDA預計在1,080萬美元至1,100萬美元之間,較2025年第一季的890萬美元成長22.5%。 該公司進一步指出,截至2026年3月31日,年度經常性收入(ARR)預計為2.489億美元,較2025年3月31日的2.251億美元成長10.6%。該公司補充說:“由於匯率波動的影響,本季ARR減少了140萬美元。” Docebo 也修訂了截至 2026 年 12 月 31 日的財年業績預期。該公司目前預計 2026 財年總營收將在 2.71 億美元至 2.73 億美元之間,高於先前預期的 2.675 億美元至 2.695 億美元。 FactSet 匯總的該財年銷售額一致預期為 2.681 億美元。 該公司還將截至 2026 年 12 月 31 日的財年調整後 EBITDA 預期範圍從先前預期的 5,250 萬美元至 5,450 萬美元上調至 5,450 萬美元至 5,650 萬美元。 截至 2026 年 12 月 31 日的財年,該公司目前預計訂閱收入將在 2.535 億美元至 2.555 億美元之間,高於先前預期的 2.515 億美元至 2.535 億美元。 「Docebo在2026年開局表現卓越,各項業績均超出預期,進一步鞏固了我們在市場上的領先地位。我們的出色表現既體現了公司嚴謹的執行力,也反映了市場對我們人工智能勞動力準備平台日益增長的需求,因為在日益複雜的運營環境中,各組織都將勞動力準備放在首位。」總裁兼總裁兼執行長Inspire大會今天在邁阿密拉開序幕,我們期待展示能夠進一步鞏固我們市場地位的創新成果。 正如先前宣布的那樣,該公司預計將於2026年5月8日(星期五)美股開盤前公佈2026年第一季完整財務業績。 昨日,Docebo股票(股票代號:DCBO)在加拿大上漲了3%。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB